Literature DB >> 17873031

Diminished LcrV secretion attenuates Yersinia pseudotuberculosis virulence.

Jeanette E Bröms1, Matthew S Francis, Ake Forsberg.   

Abstract

Many gram-negative bacterial pathogenicity factors that function beyond the outer membrane are secreted via a contact-dependent type III secretion system. Two types of substrates are predestined for this mode of secretion, namely, antihost effectors that are translocated directly into target cells and the translocators required for targeting of the effectors across the host cell membrane. N-terminal secretion signals are important for recognition of the protein cargo by the type III secretion machinery. Even though such signals are known for several effectors, a consensus signal sequence is not obvious. One of the translocators, LcrV, has been attributed other functions in addition to its role in translocation. These functions include regulation, presumably via interaction with LcrG inside bacteria, and immunomodulation via interaction with Toll-like receptor 2. Here we wanted to address the significance of the specific targeting of LcrV to the exterior for its function in regulation, effector targeting, and virulence. The results, highlighting key N-terminal amino acids important for LcrV secretion, allowed us to dissect the role of LcrV in regulation from that in effector targeting/virulence. While only low levels of exported LcrV were required for in vitro effector translocation, as deduced by a cell infection assay, fully functional export of LcrV was found to be a prerequisite for its role in virulence in the systemic murine infection model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17873031      PMCID: PMC2168923          DOI: 10.1128/JB.00936-07

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  62 in total

1.  Yersinia YopE is targeted for type III secretion by N-terminal, not mRNA, signals.

Authors:  S A Lloyd; M Norman; R Rosqvist; H Wolf-Watz
Journal:  Mol Microbiol       Date:  2001-01       Impact factor: 3.501

2.  LcrG-LcrV interaction is required for control of Yops secretion in Yersinia pestis.

Authors:  J S Matson; M L Nilles
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

3.  Targeting exported substrates to the Yersinia TTSS: different functions for different signals?

Authors:  S A Lloyd; A Forsberg ; H Wolf-Watz; M S Francis
Journal:  Trends Microbiol       Date:  2001-08       Impact factor: 17.079

4.  LcrV is a channel size-determining component of the Yop effector translocon of Yersinia.

Authors:  A Holmström; J Olsson; P Cherepanov; E Maier; R Nordfelth; J Pettersson; R Benz; H Wolf-Watz; A Forsberg
Journal:  Mol Microbiol       Date:  2001-02       Impact factor: 3.501

5.  LcrV, a substrate for Yersinia enterocolitica type III secretion, is required for toxin targeting into the cytosol of HeLa cells.

Authors:  V T Lee; C Tam; O Schneewind
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

6.  Roles of LcrG and LcrV during type III targeting of effector Yops by Yersinia enterocolitica.

Authors:  K L DeBord; V T Lee; O Schneewind
Journal:  J Bacteriol       Date:  2001-08       Impact factor: 3.490

7.  Yersinia enterocolitica type III secretion-translocation system: channel formation by secreted Yops.

Authors:  F Tardy; F Homblé; C Neyt; R Wattiez; G R Cornelis; J M Ruysschaert; V Cabiaux
Journal:  EMBO J       Date:  1999-12-01       Impact factor: 11.598

Review 8.  Vaccination against bubonic and pneumonic plague.

Authors:  R W Titball; E D Williamson
Journal:  Vaccine       Date:  2001-07-20       Impact factor: 3.641

9.  Growth of Yersinia pseudotuberculosis in mice occurs independently of Toll-like receptor 2 expression and induction of interleukin-10.

Authors:  Victoria Auerbuch; Ralph R Isberg
Journal:  Infect Immun       Date:  2007-04-09       Impact factor: 3.441

10.  Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization.

Authors:  R Nakajima; V L Motin; R R Brubaker
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

View more
  14 in total

1.  Impact of the N-terminal secretor domain on YopD translocator function in Yersinia pseudotuberculosis type III secretion.

Authors:  Ayad A A Amer; Monika K Åhlund; Jeanette E Bröms; Åke Forsberg; Matthew S Francis
Journal:  J Bacteriol       Date:  2011-09-30       Impact factor: 3.490

2.  Autoproteolysis of YscU of Yersinia pseudotuberculosis is important for regulation of expression and secretion of Yop proteins.

Authors:  Ann-Catrin Björnfot; Moa Lavander; Ake Forsberg; Hans Wolf-Watz
Journal:  J Bacteriol       Date:  2009-04-24       Impact factor: 3.490

3.  Amino acid and structural variability of Yersinia pestis LcrV protein.

Authors:  Andrey P Anisimov; Svetlana V Dentovskaya; Evgeniy A Panfertsev; Tat'yana E Svetoch; Pavel Kh Kopylov; Brent W Segelke; Adam Zemla; Maxim V Telepnev; Vladimir L Motin
Journal:  Infect Genet Evol       Date:  2009-10-14       Impact factor: 3.342

4.  Control of effector export by the Pseudomonas aeruginosa type III secretion proteins PcrG and PcrV.

Authors:  Pei-Chung Lee; Charles M Stopford; Amanda G Svenson; Arne Rietsch
Journal:  Mol Microbiol       Date:  2010-02       Impact factor: 3.501

5.  YopN Is Required for Efficient Effector Translocation and Virulence in Yersinia pseudotuberculosis.

Authors:  Sarp Bamyaci; Sofie Ekestubbe; Roland Nordfelth; Saskia F Erttmann; Tomas Edgren; Åke Forsberg
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

6.  Translational regulation of Yersinia enterocolitica mRNA encoding a type III secretion substrate.

Authors:  Karyl S Kopaskie; Katherine Given Ligtenberg; Olaf Schneewind
Journal:  J Biol Chem       Date:  2013-10-24       Impact factor: 5.157

7.  YscU cleavage and the assembly of Yersinia type III secretion machine complexes.

Authors:  Kelly E Riordan; Olaf Schneewind
Journal:  Mol Microbiol       Date:  2008-04-29       Impact factor: 3.501

8.  Human anti-plague monoclonal antibodies protect mice from Yersinia pestis in a bubonic plague model.

Authors:  Xiaodong Xiao; Zhongyu Zhu; Jennifer L Dankmeyer; Michael M Wormald; Randy L Fast; Patricia L Worsham; Christopher K Cote; Kei Amemiya; Dimiter S Dimitrov
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

9.  A translocator-specific export signal establishes the translocator-effector secretion hierarchy that is important for type III secretion system function.

Authors:  Amanda G Tomalka; Charles M Stopford; Pei-Chung Lee; Arne Rietsch
Journal:  Mol Microbiol       Date:  2012-11-05       Impact factor: 3.501

10.  Yersinia enterocolitica type III secretion of YopR requires a structure in its mRNA.

Authors:  Bill Blaylock; Joseph A Sorg; Olaf Schneewind
Journal:  Mol Microbiol       Date:  2008-10-02       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.